| Anthony J Barile, MD | |
|
205 E Nasa Blvd, Suite 200, Melbourne, FL 32901 | |
| (321) 676-6322 | |
| (321) 676-6434 |
| Full Name | Anthony J Barile |
|---|---|
| Gender | Male |
| Speciality | Infectious Disease |
| Experience | 31 Years |
| Location | 205 E Nasa Blvd, Melbourne, Florida |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1467445031 | NPI | - | NPPES |
| 261139200 | Medicaid | FL | |
| 440003334 | Other | FL | RR MEDICARE |
| 58762Y | Other | FL | MEDICARE |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RI0200X | Internal Medicine - Infectious Disease | ME82074 (Florida) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Memorial Mission Hospital And Asheville Surgery Ce | Asheville, NC | Hospital |
| The Mcdowell Hospital | Marion, NC | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Mission Health Community Multispecialty Providers Llc | 9537468574 | 577 |
News Archive
Today, on World Heart Day, Societi, the UK Kawasaki Disease Foundation is campaigning to protect tiny hearts — by highlighting the urgent need for awareness of Kawasaki Disease – the leading cause of acquired heart disease in U.K. children.
An extended trial of a drug for people with type 2 diabetes has confirmed that the oral DPP-4 inhibitor linagliptin is a safe and effective means of lowering glucose levels for up to 102 weeks, either on its own or in combination with other selected oral anti-diabetic medication.
Given that almost 70% of young adults with Asperger syndrome have suffered from depression, it is vital that psychiatric care staff are aware of this so that patients are given the right treatment, reveals research from the Sahlgrenska Academy at the University of Gothenburg, Sweden.
GenomOncology today announced that UCLA Health has adopted the GO Clinical Workbench to accelerate analysis and reporting for its tumor DNA profiling tests.
Despite increased vaccine distribution and a significant decrease in the number of COVID-19 cases in Canada, the future of the pandemic is still a major concern, based on the possibility of a resurgence in the short term as well as long term and an understanding of the future of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) immunity. It is not clear if the Canadian population will reach herd immunity or if there is a risk of future resurgence of the virus in the Fall or Winter.
› Verified 5 days ago
| Entity Name | Mission Health Community Multispecialty Providers Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1457719130 PECOS PAC ID: 9537468574 Enrollment ID: O20160426001883 |
News Archive
Today, on World Heart Day, Societi, the UK Kawasaki Disease Foundation is campaigning to protect tiny hearts — by highlighting the urgent need for awareness of Kawasaki Disease – the leading cause of acquired heart disease in U.K. children.
An extended trial of a drug for people with type 2 diabetes has confirmed that the oral DPP-4 inhibitor linagliptin is a safe and effective means of lowering glucose levels for up to 102 weeks, either on its own or in combination with other selected oral anti-diabetic medication.
Given that almost 70% of young adults with Asperger syndrome have suffered from depression, it is vital that psychiatric care staff are aware of this so that patients are given the right treatment, reveals research from the Sahlgrenska Academy at the University of Gothenburg, Sweden.
GenomOncology today announced that UCLA Health has adopted the GO Clinical Workbench to accelerate analysis and reporting for its tumor DNA profiling tests.
Despite increased vaccine distribution and a significant decrease in the number of COVID-19 cases in Canada, the future of the pandemic is still a major concern, based on the possibility of a resurgence in the short term as well as long term and an understanding of the future of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) immunity. It is not clear if the Canadian population will reach herd immunity or if there is a risk of future resurgence of the virus in the Fall or Winter.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Anthony J Barile, MD 3300 S Fiske Blvd, Rockledge, FL 32955-4306 Ph: (321) 434-1981 | Anthony J Barile, MD 205 E Nasa Blvd, Suite 200, Melbourne, FL 32901 Ph: (321) 676-6322 |
News Archive
Today, on World Heart Day, Societi, the UK Kawasaki Disease Foundation is campaigning to protect tiny hearts — by highlighting the urgent need for awareness of Kawasaki Disease – the leading cause of acquired heart disease in U.K. children.
An extended trial of a drug for people with type 2 diabetes has confirmed that the oral DPP-4 inhibitor linagliptin is a safe and effective means of lowering glucose levels for up to 102 weeks, either on its own or in combination with other selected oral anti-diabetic medication.
Given that almost 70% of young adults with Asperger syndrome have suffered from depression, it is vital that psychiatric care staff are aware of this so that patients are given the right treatment, reveals research from the Sahlgrenska Academy at the University of Gothenburg, Sweden.
GenomOncology today announced that UCLA Health has adopted the GO Clinical Workbench to accelerate analysis and reporting for its tumor DNA profiling tests.
Despite increased vaccine distribution and a significant decrease in the number of COVID-19 cases in Canada, the future of the pandemic is still a major concern, based on the possibility of a resurgence in the short term as well as long term and an understanding of the future of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) immunity. It is not clear if the Canadian population will reach herd immunity or if there is a risk of future resurgence of the virus in the Fall or Winter.
› Verified 5 days ago
Dr. Nathan D Allison, M.D. Infectious Disease Medicare: Accepting Medicare Assignments Practice Location: 8725 N Wickham Rd, Suite 302, Melbourne, FL 32940 Phone: 321-434-9230 Fax: 321-434-9231 | |
Dr. Olga Dorjima Emgushov, MD,MPH Infectious Disease Medicare: Medicare Enrolled Practice Location: 1350 Hickory St, Melbourne, FL 32901 Phone: 321-434-1771 Fax: 321-434-1775 | |
Dr. Audrius J Bredikis, M.D. Infectious Disease Medicare: Accepting Medicare Assignments Practice Location: 1223 Gateway Dr Ste 2e, Melbourne, FL 32901 Phone: 321-361-5564 Fax: 321-956-2542 | |
Dr. Christopher Ernest Baird, M.D. Infectious Disease Medicare: Accepting Medicare Assignments Practice Location: 1350 Hickory St, Melbourne, FL 32901 Phone: 321-434-1771 | |
Craig J Badolato, MD Infectious Disease Medicare: Accepting Medicare Assignments Practice Location: 1430 Pine St, Melbourne, FL 32901 Phone: 321-674-5050 Fax: 321-952-6296 | |
Dr. Timothy Orphanides, MD Infectious Disease Medicare: Accepting Medicare Assignments Practice Location: 1223 Gateway Dr Ste 2b, Melbourne, FL 32901 Phone: 321-549-0736 Fax: 321-952-2330 | |
Dr. Caleb Bert Long, D.O. Infectious Disease Medicare: Accepting Medicare Assignments Practice Location: 250 N Wickham Rd, Melbourne, FL 32935 Phone: 321-338-1618 Fax: 321-433-2311 |